Hammond Matthew

Director at Research Alliance Corp IV · on record since Jul 10, 2026
Director at Research Alliance Corp III · on record since May 19, 2026
Chief Executive Officer at Research Alliance Corp III · on record since May 19, 2026
10% owner at Research Alliance Corp III · on record since May 19, 2026
Director at POINT Biopharma Global Inc. · on record since Jul 7, 2020
Chief Financial Officer at POINT Biopharma Global Inc. · on record since Jul 7, 2020
Director at Research Alliance Corp. II · on record since Mar 17, 2021
Chief Investment Officer at Research Alliance Corp. II · on record since Mar 17, 2021
Chief Executive Officer at Research Alliance Corp IV · on record since Jul 10, 2026
10% owner at Research Alliance Corp IV · on record since Jul 10, 2026

Insider trading activity of Hammond Matthew

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Research Alliance Corp IVListing unverified	Jul 16, 2026	Award	275,000	10.00 USD	$2.8M		SEC
Research Alliance Corp IIIListing unverified	May 21, 2026	Award	275,000	10.00 USD	$2.8M		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Research Alliance Corp IVListing unverified	Jul 16, 2026	Award	275,000	10.00 USD	$2.8M		SEC
Research Alliance Corp IIIListing unverified	May 21, 2026	Award	275,000	10.00 USD	$2.8M		SEC